REMINDER: Join the FDA's Digital Endpoints Challenge

U.S. Food and Drug Administration sent this bulletin at 07/16/2024 09:01 AM EDT

If your email program has trouble displaying this email, view as a webpage.

U.S. Food and Drug Administration, Center for Devices and Radiological Health

Reminder: The Digitally-Derived Endpoints for Freezing-of-Gait Detection (DEFoGD) Challenge is Underway

A female health care professional assists a senior man with walking in his home.

Medical device developers, tech innovators, software developers, and academic researchers, join the Digitally-Derived Endpoints for Freezing-of-Gait Detection (DEFoGD) Challenge and help improve the development and assessment of endpoints related to Parkinson’s disease.

People with Parkinson’s disease may experience temporary, involuntary periods where they are unable to move their feet when trying to walk, known as freezing of gait. This lack of mobility can impact a patient’s balance and increase their risk of falling.

The DEFoGD Challenge — hosted by the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) and Office of Digital Transformation’s precisionFDA — is seeking artificial intelligence (AI) models to identify and predict freezing of gait (FoG) events related to Parkinson’s disease. These AI models will foster digital health innovation and may speed up the development of new and effective approaches to helping people with this disease.

The top performing AI models from Phase 1 will be deployed and evaluated against validated FoG data in Phase 2, helping to determine best practices for using AI-enabled models to develop and validate measures from wearable devices and smartphones. The DEFoGD Challenge launched on May 28, 2024.

The DEFoGD Challenge is underway, and submissions will be accepted through August 2, 2024.

Join the Challenge

The Challenge is hosted by:

The Digital Health Center of Excellence
The Office of Science and Engineering Laboratories
The Office of Digital Transformation’s precisionFDA

PrecisionFDA is a secure, collaborative, high-performance computing platform that builds a community of experts around the analysis of biological datasets in order to advance precision medicine.

This Challenge is part of CDRH’s work to advance health care by fostering responsible and high-quality digital health innovation.

Questions?

If you have questions about the DEFoGD Challenge, contact precisionFDA at precisionfda@fda.hhs.gov.

Manage Subscriptions | Unsubscribe All | Help